These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 16019891)
1. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. Fu X; Ping Q; Gao Y J Microencapsul; 2005 Feb; 22(1):57-66. PubMed ID: 16019891 [TBL] [Abstract][Full Text] [Related]
2. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. Fu X; Ping Q; Gao Y J Microencapsul; 2005 Nov; 22(7):705-14. PubMed ID: 16421082 [TBL] [Abstract][Full Text] [Related]
3. [Effect of preparation technique on in vitro release mechanism of huperzine A microspheres]. Fu XD; Gao YL; Ping QN Yao Xue Xue Bao; 2006 Jul; 41(7):589-94. PubMed ID: 17007348 [TBL] [Abstract][Full Text] [Related]
4. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Yang YY; Chia HH; Chung TS J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548 [TBL] [Abstract][Full Text] [Related]
5. Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chu D; Tian J; Liu W; Li Z; Li Y Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):625-8. PubMed ID: 17409558 [TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate. Sehra S; Dhake AS J Microencapsul; 2005 Aug; 22(5):521-8. PubMed ID: 16361195 [TBL] [Abstract][Full Text] [Related]
8. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277 [TBL] [Abstract][Full Text] [Related]
9. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Blanco D; Alonso MJ Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633 [TBL] [Abstract][Full Text] [Related]
10. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
11. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres. Yang Y; Gao Y; Mei X Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467 [TBL] [Abstract][Full Text] [Related]
12. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid). Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application. Wu XS Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184 [TBL] [Abstract][Full Text] [Related]
14. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery. Wang N; Wu XS; Li JK Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery. Haddadi A; Farboud ES; Erfan M; Aboofazeli R J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid). Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556 [TBL] [Abstract][Full Text] [Related]
17. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro]. Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137 [TBL] [Abstract][Full Text] [Related]
18. PLGA microspheres with high drug loading and high encapsulation efficiency prepared by a novel solvent evaporation technique. Bao W; Zhou J; Luo J; Wu D J Microencapsul; 2006 Aug; 23(5):471-9. PubMed ID: 16980270 [TBL] [Abstract][Full Text] [Related]
19. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531 [TBL] [Abstract][Full Text] [Related]
20. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A. Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR Curr Drug Deliv; 2006 Oct; 3(4):343-9. PubMed ID: 17076635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]